Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Thrombosis
•
Hematology
•
Benign Hematology
•
Hemostasis/Thrombosis
Given recent data on similar outcomes for isolated distal and proximal DVTs improved with DOAC therapy, will your decision to anticoagulate all provoked, isolated distal DVTs change?
https://onlinelibrary.wiley.com/doi/10.1111/jth.15416
Related Questions
What is the ideal period to wait until curative surgery for patients with acute pulmonary embolism and solid malignancy?
For patients with incidental findings of venous thromboembolism during workup of a treatable malignancy, how do you approach discontinuation after the treatment is complete?
For a patient with ESRD on hemodialysis with recurrent AV fistula thrombosis and a finding of Protein C deficiency based on decreased plasma activity level on thrombophilia workup, what is recommended in terms of anticoagulation management?
Can you use apixaban or rivaroxaban in case of dabigatran failure?
How do you manage me anticoagulation in a patient with May Thurner Syndrome, who does not have history of thrombosis, and becomes pregnant?
How do you treat a patient with warfarin failure, with therapeutic INR 2-3 at the time of DVT, and no underlying malignancy or hypercoagulable state?
How long post operatively do you wait before transitioning from parenteral anticoagulation to oral anticoagulants after pulmonary thromboendarterectomy for CTEPH?
How long do you anticoagulate for cirrhosis patients who have portal vein thrombosis extending to the mesenteric veins?
How would you manage a patient with morbid obesity who presents with new symptomatic pulmonary embolism a few days after he was started on DOAC for DVT?
Are SCDs contraindicated in patients with acute DVTs?